Xenetic Biosciences Inc. (XBIO)
NASDAQ: XBIO
· Real-Time Price · USD
3.22
0.22 (7.33%)
At close: Jun 02, 2025, 3:57 PM
3.29
2.17%
After-hours: Jun 02, 2025, 06:02 PM EDT
Xenetic Biosciences Revenue Breakdown
| Period Ending | Dec 31, 2020 |
|---|---|
| Royalty Revenue Revenue | 437K |
| Royalty Revenue Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 656.64K | 705.71K | 745.73K | 1.13M | 834.91K | 952K | 737.24K | 945.95K | 925.74K | 857.17K | 863.23K | 1.03M | 907.31K | 977.58K | 945.12K | 890.7K | 930.58K | 880.56K | 804.15K | 787.49K | 927.88K | 834.52K | 2.14M | 890.78K | 863.37K | 1.12M | 1.08M | 1.07M | 1.12M | 1.99M | 1.34M | 1.97M | 1.63M | 2.35M | 1.36M | 1.56M | 1.42M | 1.66M | 2.98M | 803.4K | 935.23K |
| Selling, General, and Administrative Revenue Growth | -6.95% | -5.37% | -34.01% | +35.35% | -12.30% | +29.13% | -22.06% | +2.18% | +8.00% | -0.70% | -15.89% | +13.11% | -7.19% | +3.43% | +6.11% | -4.28% | +5.68% | +9.50% | +2.12% | -15.13% | +11.19% | -61.05% | +140.52% | +3.17% | -23.24% | +4.24% | +1.17% | -4.95% | -43.59% | +48.02% | -31.81% | +20.55% | -30.53% | +73.04% | -12.70% | +9.51% | -14.57% | -44.22% | +271.48% | -14.10% | n/a |
| Research and Development Revenue | 879.03K | 1.04M | 367.99K | 933.77K | 944.32K | 975.63K | 1.02M | 903.24K | 595.28K | 1.19M | 398.8K | 2.08M | 1.1M | 1.23M | 780.15K | 524.55K | 629.73K | 490.79K | 573.06K | 307.9K | 359.65K | 417.4K | 3.52M | 487.52K | 463.78K | 514.73K | 735.88K | 927.07K | 706.27K | 1.08M | 884.8K | 932.93K | 1.22M | 711.49K | 891.83K | 41.71M | 429.28K | 1.03M | 816.32K | 555.74K | 1.04M |
| Research and Development Revenue Growth | -15.66% | +183.23% | -60.59% | -1.12% | -3.21% | -4.41% | +12.99% | +51.74% | -50.11% | +199.18% | -80.80% | +88.62% | -10.39% | +57.54% | +48.73% | -16.70% | +28.31% | -14.36% | +86.12% | -14.39% | -13.84% | -88.14% | +622.15% | +5.12% | -9.90% | -30.05% | -20.62% | +31.26% | -34.62% | +22.09% | -5.16% | -23.60% | +71.63% | -20.22% | -97.86% | +9615.13% | -58.20% | +25.79% | +46.89% | -46.31% | n/a |